News - BioSpace
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who …
BioSpace: Biotech, Pharmaceutical and Clinical Research News
Dec 11, 2010 · BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals …
Latest News & Press Releases - BioSpace
4 days ago · Browse the latest news from BioSpace, and press releases from around the industry. Want to filter by date, keyword, and more? Search here.
Pfizer, Geron Downsize To Streamline Costs - BioSpace
Dec 12, 2025 · That news came soon after two deaths were linked to Sarepta’s Duchenne muscular dystrophy treatment Elevidys. TScan Therapeutics Nov. 3 T cell therapy biotech …
Biopharma Mergers & Acquisitions - BioSpace
Get the latest news on biotech funding, stocks, mergers and acquisitions, IPOs, bankruptcies, and more from BioSpace.
Red Biotechnology Market Size to Hit USD 649.31 Billion by 2033
Dec 2, 2024 · Biotechnology Reagents & Kits Market : The global biotechnology reagents & kits market was estimated at USD 466.20 billion in 2023 and is expected to hit over USD 1,323.74 …
Genetown - BioSpace
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who …
Biotech Stocks Fall After FDA Names Vinay Prasad To Succeed
May 6, 2025 · The analysts noted, however, that “Makary does not seem to want to disrupt oncology and rare disease approvals.” The S&P Biotech ETF fell by more than 5% upon news …
Biotech Bay - BioSpace
Dec 4, 2025 · The Biotech Bay Hotbed includes the San Francisco Bay, Menlo Park and Palo Alto regions of Northern California. California is a dominant force in the life sciences sector, hosting …
Vir Leans Into Immunology Roots After Flamed-Out COVID Fame
Feb 12, 2025 · Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer stepped in as CEO to answer a critical question: …